Connecticut 2017 Regular Session

Connecticut House Bill HB07010

Introduced
2/2/17  
Introduced
2/2/17  
Refer
2/2/17  
Report Pass
3/27/17  
Refer
4/7/17  
Refer
4/7/17  
Report Pass
4/13/17  
Refer
5/10/17  

Caption

An Act Concerning Opioids And Substance Use Disorders.

Impact

By mandating insurance coverage for inpatient substance abuse services until a patient's health condition is stabilized, HB 07010 fundamentally alters the insurance landscape for addiction treatment. This legislation also creates an electronic portal to share real-time data on the availability of treatment beds and outpatient slots, which is expected to enhance accessibility to necessary services. The bill reflects an intentional shift towards proactive public health measures aimed at preventing and addressing substance abuse directly within the community.

Summary

House Bill 07010, known as 'An Act Concerning Opioids and Substance Use Disorders', aims to address the opioid crisis by implementing comprehensive measures that support individuals suffering from substance use disorders. This bill reforms the process for emergency commitment to treatment facilities for those who are dangerous to themselves or others due to substance intoxication. It allows for quicker access to emergency treatment for individuals who may not be intoxicated at the time of application if a physician determines they need immediate care. The bill stresses a multi-faceted approach towards the management of opioid use and enhances support for treatment facilities.

Sentiment

The sentiment around HB 07010 appears largely positive, especially among healthcare advocates and organizations tackling substance abuse issues. Many view it as a necessary step in combating the opioid epidemic, emphasizing the importance of accessibility to treatment. However, there may be pockets of contention related to the resources that treatment facilities need to implement these changes effectively, as well as concerns regarding the funding and support for the required marketing campaigns to raise public awareness about opioid use and available treatments.

Contention

Notable points of contention surrounding HB 07010 include discussions on the adequacy of funding for treatment facilities to fulfill the bill's requirements, and the capacity of these institutions to handle increased patient loads due to the enhanced commitment processes. Additionally, as treatment methodologies may vary, ensuring that guidelines for treatment are established without increasing the risks of mismanagement or abuse remains a concern for many stakeholders involved in substance use treatment.

Companion Bills

No companion bills found.

Similar Bills

CA AB1166

Liability for opioid antagonist administration.

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

CA AB1037

Public health: substance use disorder.

CA AB381

Licensed facilities: duties.

CO HB1037

Substance Use Disorders Harm Reduction

KY HB547

AN ACT relating to opioid antagonists.

KY SB56

AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

CA AB2998

Opioid overdose reversal medications: pupil administration.